<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, of note as of 12 March 2020, 379 trials for COVID‐19 had been listed on the Chinese Clinical trials Registry; by 15 March 2020 this increased to 420.
 <xref rid="apt15779-bib-0114" ref-type="ref">
  <sup>114</sup>
 </xref> (Table 
 <xref rid="apt15779-sup-0001" ref-type="supplementary-material">S1</xref>). Of these trials, 122 (29%) involved the examination of Chinese medicines for the treatment of COVID‐19. As clinicians we need to be aware of the information available to patients seeking ‘natural’ alternative therapies and in the absence of clinical evidence, care should be taken when making such suggestions to alleviate panic and inappropriate prescribing.
</p>
